Fette Compacting America
The FEC40 Capsule Filler can produce up to 400,000 capsules/hr-nearly twice the volume of any competitor. Its remarkably small footprint makes machine reconfiguration due to floor space issues unnecessary. Extraordinarily high performance-to-footprint ratio is made possible by Fette Compacting’s patented Duplex Concept, enabling FEC40 to feature a dual capsule filling process. The result is significant production savings (up to 30% per 1000 capsules).
Fette Compacting America
400 Forge Way, Rockaway, NJ 07866
tel. 973.586.8722 • INTERPHEX Booth #2505C
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
